Catalyst
Slingshot members are tracking this event:
Merck (MRK) to Present New Data on ZEPATIER (elbasvir and grazoprevir) and Chronic Hepatitis C Clinical Development Programs at The Liver Meeting 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MRK | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 12, 2016
Occurred Source:
http://www.mercknewsroom.com/news-release/hepatitis-c-newsroom/merck-announces-presentation-new-findings-zepatier-elbasvir-and-gr
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Zepatier, Elbasvir, Grazoprevir, Chronic Hepatitis C
